Praluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates). Praluzatamab can be used for research of cancers.
Molecular Weight:
146900
Purity:
99.5%
CAS Number:
[2145109-70-0]
* VAT and and shipping costs not included. Errors and price changes excepted